» Articles » PMID: 21186954

Hashimoto's Thyroiditis Affects Symptom Load and Quality of Life Unrelated to Hypothyroidism: a Prospective Case-control Study in Women Undergoing Thyroidectomy for Benign Goiter

Overview
Journal Thyroid
Date 2010 Dec 29
PMID 21186954
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Hashimoto's thyroiditis (HT) is a common disease, and is the most prevalent cause of hypothyroidism. Symptoms and diseases associated with HT are considered to be caused by hypothyroidism. We hypothesized that higher antithyroperoxidase (anti-TPO) antibody levels would be associated with an increased symptom load and a decreased quality of life in a female euthyroid patient collective.

Methods: In a prospective cohort study 426 consecutive euthyroid female patients undergoing thyroid surgery for benign thyroid disease were included. Main outcome measures were preoperative anti-TPO levels, a symptom questionnaire and the SF-36 questionnaire, and lymphocytic infiltration of the thyroid tissue as evaluated by histology.

Results: Histology revealed HT in 28/426 (6.6%) subjects. To maximize the sum of the predictive values, a cut-off point for anti-TPO of 121.0 IU/mL was calculated (sensitivity 93.3% [95% confidence interval: 77.9%-99.0%]; specificity 94.7% [95% confidence interval: 92.0%-96.7%]) to predict the presence of histological signs of HT. The mean number of reported symptoms was significantly higher in patients with anti-TPO levels >121.0 IU/mL than in the other group (6.7 ± 2.5 vs. 4.1 ± 2.8; p < 0.001). There were no differences in preoperative thyroid-stimulating hormone levels (1.7 ± 1.3 vs. 1.5 ± 1.4 μU/mL, respectively; p = 0.155). Chronic fatigue, dry hair, chronic irritability, chronic nervousness, a history of breast cancer and early miscarriage, and lower quality-of-life levels were significantly associated with anti-TPO levels exceeding the cut-off point (p < 0.05).

Conclusions: Women with HT suffer from a high symptom load. Hypothyroidism is only a contributing factor to the development of associated conditions.

Citing Articles

Metabolomics-based treatment for chronic diseases: results from a multidisciplinary clinical study.

Tsoukalas D, Sarandi E, Fragoulakis V, Xenidis S, Mhliopoulou M, Charta M BMJ Nutr Prev Health. 2025; 7(2):e000883.

PMID: 39882279 PMC: 11773651. DOI: 10.1136/bmjnph-2024-000883.


Thyroid antibodies in Hashimoto's thyroiditis patients are positively associated with inflammation and multiple symptoms.

Li J, Huang Q, Sun S, Zhou K, Wang X, Pan K Sci Rep. 2024; 14(1):27902.

PMID: 39537841 PMC: 11561229. DOI: 10.1038/s41598-024-78938-7.


Analysis of factors influencing the dose of levothyroxine treatment in adequately controlled hypothyroid patients of different etiologies.

Stempler M, Bakos B, Solymosi T, Kiss A, Armos R, Szili B Heliyon. 2024; 10(20):e39639.

PMID: 39502224 PMC: 11535356. DOI: 10.1016/j.heliyon.2024.e39639.


Effects of calorie-restricted diet on health state and intestinal flora in Hashimoto's thyroiditis patients: Study protocol for a randomized controlled trial.

Huang Q, Pan K, Zhang Y, Li S, Li J Asia Pac J Clin Nutr. 2024; 33(3):397-404.

PMID: 38965727 PMC: 11397562. DOI: 10.6133/apjcn.202409_33(3).0010.


Evaluation of Health-Related Quality of Life in Patients with Euthyroid Hashimoto's Thyroiditis under Long-Term Levothyroxine Therapy: A Prospective Case-Control Study.

Tabakoglu N, Celik M J Clin Med. 2024; 13(11).

PMID: 38892793 PMC: 11173285. DOI: 10.3390/jcm13113082.